SIAD Healthcare have signed a cooperation agreement to develop, manufacture and market a new line of cryopreservation bags for stem cells and tissues.

The agreement with HAEMOPHARM Healthcare will allow the Life Science Division of SAID to pursue its development plans based on the continuous efforts in the research of innovative solutions to meet the needs of the cryopreservation banks.

The agreement also presents HAEMOPHARM with the opportunity to widen its presence in a new market segment, which is expected to have important future developments.

The new product line is due to be available next summer and will be sequentially introduced in the various international markets.